Cardio Diagnostics Holdings, Inc.
CDIO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $422.7K in total; no superinvestor holds it.
Other share classesCDIOW
Q1 2025 vs. Q4 2024
How the institutions holding Cardio Diagnostics Holdings, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 23 | 23 | 0 |
| Shares | 2.57M | 2.54M | −34.4K (−1.3%) |
| Value | $2.36M | $836.3K | −$1.52M (−64.5%) |
New holders (3)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mariner, LLC | 50,000 | $16.5K | 0.00% |
| Integrated Wealth Concepts LLC | 40,000 | $13.2K | 0.00% |
| JPMorgan Chase & Co | 1,500 | $495 | 0.00% |
Sold out (3)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Millennium Management LLC | 256,941 | $235.6K |
| Scientech Research LLC | 34,494 | $31.6K |
| Citigroup Inc | 900 | $825 |